- Large, Long-term Study Shows GSK's Rosiglitazone has no Increased ... - Business Wire India (press release)
- Red tape makes this R&D firm look to US - Indian Express
- Currying favour with brain - Saga Health News
- Toxicology meet starts at GADVASU - Indian Express
- Ayurveda doctors sharpen skills with latest technology - Indian Express
Most Read Articles - Indian Express
Indian ExpressMost Read ArticlesIndian Express, IndiaThis data is very relevant in the Indian context, given that India has over 42 million diabetics and every fifth diabetic in the world is a native Asian Indian" said Dr Sadhna Joglekar, GlaxoSmithKline's VP Medical, Regulatory and Clinical Research, ...

